Determination of human papillomavirus type 16 genotype and construction of cloning vector pTZ57R encoding HPV16 E7 gene

Saudi Medical Journal

Volumn 28, Issue 10, 2007, Pages 1511-1515

  Meshkat, Zahra ^a   Soleimanjahi, Hoorieh ^a   Mahmoudi, Mahmoud ^b   Mirshahabi, Hessam ^a   Hassan, Zuhair M ^a   Ghaffari, Saeed R ^c   Sabokbar, Tayebeh ^c  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b Department of Electrical Engineering   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; PROTEIN E7;

ARTICLE; CLONING VECTOR; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; GENE AMPLIFICATION; GENE SEQUENCE; GENE TARGETING; GENOTYPE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; IRAN; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMID; POLYMERASE CHAIN REACTION; RESTRICTION MAPPING; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; UTERINE CERVIX CANCER;

FEMALE; GENE TARGETING; GENETIC VECTORS; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMANS; IRAN; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS VACCINES; POLYMERASE CHAIN REACTION; UTERINE CERVICAL NEOPLASMS;

EID: 35948994147     PISSN: 03795284     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Munger K, Baldwin A, Edwards KM, Hayakawa H, Nguyen CL, Owens M, et al. Mechanisms of human papillomavirus-induced oncogenesis. J Virol 2004; 78: 11451-11460.
2. Streeck RE. A short introduction to papillomavirus biology. Intervirology 2002; 45: 287-289.
3. Sotlar K, Diemer D, Dethleffs A, Hack Y, Stubner A, Vollmer N, et al. Detection and typing of human papillomavirus by E6 nested multiplex PCR. J Clin Microbiol 2004; 42: 3176-3184.
4. Peh WL, Brandsma JL, Christensen ND, Cladel NM, Wu X, Doorbar J. The viral E4 protein is required for the completion of the cottontail rabbit papillomavirus productive cycle in vivo. J Virol 2004; 78: 2142-2151.
5. Roden RBS, Yutzy IVWH, Fallon R, Inglis S, Lowy DR, Schiller JT. Rapid communication: Minor capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes. Virology 2000; 270: 254-257.
6. Jacobs MV, Snijders PJ, van den Brule AJ, Helmerhorst TJ, Meijer CJ, Walboomers JM. A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 1997; 35: 791-795.
7. Kawana K, Yoshikawa H, Taketani Y, Yoshiike K, Kanda T. Common neutralization epitope in minor capsid protein L2 of human papillomavirus types 16 and 6. J Virol 1999; 73: 6188-6190.
8. Thomas KK, Hughes JP, Kuypers JM, Kiviat NB, Lee SK, Adam DE, et al. Concurrent and sequential acquisition of different genital human papillomavirus types. J Infect Dis 2000; 182: 1097-1102.
9. Doorbar J. The papillomavirus life cycle. J Clin Virol 2005; 32 Suppl 1: S7-S15.
10. Meschede W, Zumbach K, Braspenning J, Scheffner M, Benitez-Bribiesca L, Luande J, et al. Antibodies against early proteins of human papillomaviruses as diagnostic markers for invasive cervical cancer. J Clin Microbiol 1998; 36: 475-480.
11. Heck DV, Yee CL, Howley PM, Munger K. Efficiency of binding to the retinoblastoma protein correlates with the transforming capacity of the E7 oncoproteins of the human papillomaviruses. Proc Natl Acad Sci USA 1992; 89: 4442-4446.
12. Chellappan S, Kraus VB, Kroger B, Munger K, Howley PM, Phelps WC, et al. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between the transcription factor E2F and the retinoblastoma gene product. Proc Natl Acad Sci USA 1992; 89: 4549-4553.
13. Cao W, Hashibe M, Rao JY. Comparison of methods for DNA extraction from paraffin-embedded tissues and buccal cells. Cancer Detect Prev 2003; 27: 397-404.
14. Coombs NJ, Gough AC, Primrose JN. Optimisation of DNA and RNA extraction from archival formalin-fixed tissue. Nucleic Acids Res 1999; 27: e12.
15. Sambrook J, Russell DW. Plasmids and their usefulness in molecular cloning. In: Molecular cloning. 3rd ed. New York (NY): Cold Spring Harbor; 2001. p. 31-38.
16. Resnick RM, Cornelissen MT, Wright DK, Eichinger GH, Fox HS, ter Schegget J, et al. Detection and typing of human papillomavirus in archival cervical cancer specimens by DNA amplification with consensus primers. J Natl Cancer Inst 1990; 82: 1477-1484.
17. Baay MF, Quint WG, Koudstaal J, Hollema H, Duk JM, Burger MP, et al. Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol 1996; 34: 745-747.
18. Lanham S, Herbert A, Basarab A, Watt P. Detection of cervical infections in colposcopy clinic patients. J Clin Microbiol 2001; 39: 2946-2950.
19. Cope JU, Hildesheim A, Schiffman MH, Manos MM, Lorincz AT, Burk RD, et al. Comparison of the hybrid capture tube test and PCR for detection of human papillomavirus DNA in cervical specimens. J Clin Microbiol 1997; 35: 2262-2265.
20. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. J Natl Cancer Inst 1995; 87: 796-802.
21. Breitburd F, Kirnbauer R, Hubbert NL, Nonnenmacher B, Trin-Dinh-Desmarquet C, Orth G, et al. Immunization with virus-like particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J Virol 1995; 69: 3959-3963.